A POTENT, ORALLY-ACTIVE, BALANCED AFFINITY ANGIOTENSIN-II AT(1) ANTAGONIST AND AT(2) BINDING INHIBITOR

被引:123
|
作者
DELASZLO, SE [1 ]
QUAGLIATO, CS [1 ]
GREENLEE, WJ [1 ]
PATCHETT, AA [1 ]
CHANG, RSL [1 ]
LOTTI, VJ [1 ]
CHEN, TB [1 ]
SCHECK, SA [1 ]
FAUST, KA [1 ]
KIVLIGHN, SS [1 ]
SCHORN, TS [1 ]
ZINGARO, GJ [1 ]
SIEGL, PKS [1 ]
机构
[1] MERCK RES LABS,DEPT PHARMACOL,W POINT,PA 19486
关键词
D O I
10.1021/jm00073a024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:3207 / 3210
页数:4
相关论文
共 50 条
  • [1] L-159,689 - A POTENT, ORALLY-ACTIVE, NONPEPTIDIC, BALANCED AT1/AT2 ANGIOTENSIN-II ANTAGONIST
    DELASZLO, S
    QUAGLIATO, CS
    GREENLEE, WJ
    PATCHETT, AA
    KIVLIGHN, SD
    CHANG, RS
    SIEGL, PKS
    SCHORN, TS
    FAUST, KA
    CHEN, TB
    ZINGARO, GJ
    LOTTI, VJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 64 - MEDI
  • [2] POTENT AND ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONISTS WITH EQUAL AFFINITY FOR HUMAN AT(1) AND AT(2) SUBTYPES
    CHANG, LL
    ASHTON, WT
    FLANAGAN, KL
    CHEN, TB
    OMALLEY, SS
    ZINGARO, GJ
    KIVLIGHN, SD
    SIEGL, PKS
    LOTTI, VJ
    CHANG, RSL
    GREENLEE, WJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (19) : 3741 - 3758
  • [3] TRIAZOLINONE BIPHENYLSULFONAMIDE DERIVATIVES AS ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONISTS WITH POTENT AT(1) RECEPTOR AFFINITY AND ENHANCED AT(2) AFFINITY
    ASHTON, WT
    CHANG, LL
    FLANAGAN, KL
    HUTCHINS, SM
    NAYLOR, EM
    CHAKRAVARTY, PK
    PATCHETT, AA
    GREENLEE, WJ
    CHEN, TB
    FAUST, KA
    CHANG, RSL
    LOTTI, VJ
    ZINGARO, GJ
    SCHORN, TW
    SIEGL, PKS
    KIVLIGHN, SD
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (17) : 2808 - 2824
  • [4] PHARMACOLOGICAL PROFILE OF VALSARTAN - A POTENT, ORALLY-ACTIVE, NONPEPTIDE ANTAGONIST OF THE ANGIOTENSIN-II AT1-RECEPTOR SUBTYPE
    CRISCIONE, L
    DEGASPARO, M
    BUHLMAYER, P
    WHITEBREAD, S
    RAMJOUE, HPR
    WOOD, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (02) : 761 - 771
  • [5] PHARMACOLOGY OF XR510, A POTENT ORALLY-ACTIVE NONPEPTIDE ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONIST WITH HIGH-AFFINITY FOR THE AT(2) RECEPTOR SUBTYPE
    WONG, PC
    QUAN, ML
    SAYE, JM
    BERNARD, R
    CRAIN, EJ
    MCCALL, DE
    WATSON, CA
    ZASPEL, AM
    SMITH, RD
    WEXLER, RR
    TIMMERMANS, PBMWM
    CHIU, AT
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (03) : 354 - 362
  • [6] POTENT AND ORALLY-ACTIVE TRIAZOLINONE ANGIOTENSIN-II ANTAGONISTS .2. HETEROCYCLIC AND RELATED ACYLSULFONAMIDES
    HUTCHINS, SM
    ASHTON, WT
    CHANG, LL
    FLANAGAN, KL
    CHAKRAVARTY, PK
    GREENLEE, WJ
    CHANG, RSL
    LOTTI, VJ
    KIVLIGHN, SD
    SIEGL, PKS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 81 - MEDI
  • [7] BALANCED AT(1) AND AT(2) ANGIOTENSIN-II ANTAGONISTS .3. POTENT AND ORALLY-ACTIVE 5-BETA-KETOSULFOXIDE IMIDAZOLYL BIPHENYL SULFONYLUREAS
    DEPREZ, P
    GUILLAUME, J
    CORBIER, A
    VEVERT, JP
    FORTIN, M
    HECKMANN, B
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (22) : 2617 - 2622
  • [8] VALSARTAN, A POTENT, ORALLY-ACTIVE ANGIOTENSIN-II ANTAGONIST DEVELOPED FROM THE STRUCTURALLY NEW AMINO-ACID SERIES
    BUHLMAYER, P
    FURET, P
    CRISCIONE, L
    DEGASPARO, M
    WHITEBREAD, S
    SCHMIDLIN, T
    LATTMANN, R
    WOOD, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) : 29 - 34
  • [9] PHARMACOLOGY OF LR-B/081, A NEW HIGHLY POTENT, SELECTIVE AND ORALLY-ACTIVE, NONPEPTIDE ANGIOTENSIN-II AT(1) RECEPTOR ANTAGONIST
    CIRILLO, R
    RENZETTI, AR
    CUCCHI, P
    GUELFI, M
    SALIMBENI, A
    CALIARI, S
    CASTELLUCCI, A
    EVANGELISTA, S
    SUBISSI, A
    GIACHETTI, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) : 1117 - 1124
  • [10] TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE
    CHANG, LL
    ASHTON, WT
    FLANAGAN, KL
    NAYLOR, EM
    CHAKRAVARTY, PK
    PATCHETT, AA
    GREENLEE, WJ
    BENDESKY, RJ
    CHEN, TB
    FAUST, KA
    KLING, PJ
    SCHAFFER, LW
    SCHORN, TW
    ZINGARO, GJ
    CHANG, RSL
    LOTTI, VJ
    KIVLIGHN, SD
    SIEGL, PKS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) : 115 - 120